UNICA IRIS Institutional Research Information System

DEIDDA, MARTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 191.304
NA - Nord America 7.797
AS - Asia 2.528
SA - Sud America 517
AF - Africa 59
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 202.233
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 189.593
US - Stati Uniti d'America 7.668
CN - Cina 1.033
SG - Singapore 985
SE - Svezia 489
UA - Ucraina 460
BR - Brasile 436
VN - Vietnam 214
DE - Germania 187
GB - Regno Unito 182
FI - Finlandia 151
CA - Canada 72
KR - Corea 60
FR - Francia 54
HK - Hong Kong 41
IN - India 32
MX - Messico 31
NL - Olanda 29
AT - Austria 27
AR - Argentina 23
AU - Australia 23
ZA - Sudafrica 22
PL - Polonia 21
RU - Federazione Russa 21
BE - Belgio 20
ES - Italia 19
BD - Bangladesh 18
JP - Giappone 18
TR - Turchia 17
IQ - Iraq 15
ID - Indonesia 14
EC - Ecuador 13
CL - Cile 11
IR - Iran 11
MA - Marocco 11
PH - Filippine 9
CO - Colombia 8
CU - Cuba 8
EG - Egitto 8
PK - Pakistan 8
AZ - Azerbaigian 7
JO - Giordania 7
PE - Perù 7
PY - Paraguay 7
CZ - Repubblica Ceca 6
RS - Serbia 6
UZ - Uzbekistan 6
IL - Israele 5
KZ - Kazakistan 5
TN - Tunisia 5
BG - Bulgaria 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
IE - Irlanda 4
KG - Kirghizistan 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PR - Porto Rico 4
UY - Uruguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
KE - Kenya 3
NO - Norvegia 3
OM - Oman 3
RO - Romania 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
IS - Islanda 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 202.229
Salva come PNG Salva come JPEG
Città #
Cagliari 170.148
Uta 19.040
Fairfield 909
Woodbridge 727
Ashburn 657
Houston 512
Dallas 468
Singapore 423
Chandler 406
Wilmington 396
Ann Arbor 390
Seattle 349
Nyköping 343
Boardman 325
Cambridge 316
Jacksonville 247
Beijing 240
Dearborn 210
Santa Clara 110
Los Angeles 99
Boston 98
Nanjing 98
New York 70
Shanghai 70
Hefei 67
Dong Ket 64
Helsinki 61
Ho Chi Minh City 60
Seoul 58
San Diego 55
Buffalo 53
Redwood City 50
São Paulo 43
Hong Kong 41
London 37
Shenyang 36
The Dalles 35
Nanchang 32
Guangzhou 31
Toronto 31
Munich 30
Chicago 28
Hanoi 27
Hebei 26
Milan 26
Tianjin 26
Atlanta 23
Phoenix 23
Jiaxing 20
Mountain View 19
Council Bluffs 18
Brooklyn 17
Changsha 17
Jinan 17
Nuremberg 17
Redondo Beach 17
Tokyo 17
Warsaw 17
Frankfurt am Main 16
Norwalk 16
Brussels 15
Rio de Janeiro 15
Zhengzhou 15
Auburn Hills 13
Turku 13
Denver 12
Kunming 12
Montreal 12
Quartu Sant'elena 12
Vienna 12
Wuhan 12
Chennai 11
Manchester 11
Falls Church 10
Orange 10
Quito 10
Washington 10
Belo Horizonte 9
Orem 9
Amsterdam 8
Augusta 8
Borås 8
Columbus 8
Genova 8
Haiphong 8
Johannesburg 8
Mexico City 8
Rome 8
San Mateo 8
Sestu 8
Stockholm 8
Utrecht 8
Amman 7
Brasília 7
Düsseldorf 7
Melbourne 7
Naples 7
Salvador 7
Sassari 7
Charlotte 6
Totale 198.204
Salva come PNG Salva come JPEG
Nome #
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 12.858
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.338
Metabolomic approach to profile functional and metabolic changes in heart failure 4.202
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.142
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.876
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.832
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.507
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.505
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.432
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.352
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.303
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 3.093
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 3.078
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine 2.973
Metabolomics and heart failure: a new and promising scientific approach 2.959
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 2.919
Coronary Artery Disease 2.906
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.797
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.792
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.728
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.712
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.673
Metabolomics, a promising approach to translational research in cardiology 2.651
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.506
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.474
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.367
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.357
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.250
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.235
Women-specific predictors of cardiovascular disease risk - new paradigms 2.206
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.190
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.185
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.146
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.144
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.131
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.112
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 2.085
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study 2.071
The need of a gender-corrected evidence based medicine 2.059
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 2.047
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 1.955
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? 1.941
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.940
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.906
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.870
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.825
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.823
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.789
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.756
Gender differences in cardiology: is it time for new guidelines? 1.741
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.707
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.670
Gender-specific aspects in primary and secondary prevention of cardiovascular disease 1.584
Subclinical contractility impairment in HIV-infected patients varies according to class of antiretroviral drugs 1.548
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs 1.544
Vascular damage-Coronary artery disease 1.519
Ankle-brachial index and its link to automated carotid ultrasound measurement of intima-media thickness variability in 500 Japanese coronary artery disease patients 1.511
Association of automated carotid IMT measurement and HbA1c in Japanese patients with coronary artery disease 1.492
null 1.489
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue? 1.483
null 1.471
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.463
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 1.462
Early Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance 1.386
Altered transmural contractility in women affected by cardiac X syndrome 1.377
Metabolomics: a new era in cardiology? 1.319
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 1.307
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.287
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects 1.272
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.266
Sex differences in congenital heart defects and genetically induced arrhythmias 1.263
null 1.234
Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients 1.202
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.155
Looking for the gender equality 1.128
Relationship between high values of HOMA-IR and cardiovascular response to metformin 1.124
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection 1.087
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 1.017
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 959
null 944
Impact of COVID-19 on the cardiovascular health of women: a review by the Italian Society of Cardiology Working Group on 'gender cardiovascular diseases' 919
Metabolomic approach to foetal and neonatal heart 886
Contribution of metabolomics to the understanding of nafld and nash syndromes: A systematic review 845
Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population 781
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 761
null 745
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy 720
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study 711
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 702
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 676
Subclinical contractility impairment in HIV-infected patients: dependence on the class of antiretroviral drugs 646
Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection 637
La Metabolomica: una nuova era in Cardiologia. Le nostre esperienze originali nei campi dell' insufficienza cardiaca, della cardiopatia ischemica e dell' ipertensione polmonare 633
A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics 616
Gender determinants of cardiovascular risk factors and diseases 608
Cardiac effects of L-thyroxine administration in borderline hypothyroidism 600
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 599
Cardiorespiratory Fitness, Preclinical Systolic and Dyastolic Dysfunctions and HRQoL in Men with Type 2 Diabetes 565
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 562
Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy 551
Totale 194.772
Salva come PNG Salva come JPEG
Categoria #
all - tutte 246.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 246.653
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117.748 0 0 0 0 0 4.724 3.140 2.759 1.149 2.344 2.129 1.503
2021/20229.104 1.063 579 467 814 717 670 456 511 947 845 1.006 1.029
2022/202313.092 1.267 2.022 1.775 1.157 1.140 1.093 566 849 819 765 1.039 600
2023/202414.413 724 547 614 968 1.426 2.452 2.357 919 973 935 1.243 1.255
2024/202544.484 7.462 8.569 5.317 16.410 1.493 2.395 1.659 143 321 202 220 293
2025/20263.582 433 399 908 635 674 533 0 0 0 0 0 0
Totale 202.679